TABLE 2.

Univariate and multivariate analyses for overall survival for VEGFR-2 cohort

Variable	Caucasian (n = 42)				Asian (n = 263)
	Univariate analysis			Multivariate analysis	Univariate analysis			Multivariate analysis
	HR	95 % CI	p value	p value	HR	95 % CI	p value	p value
Age	1.045	0.992–1.101	0.097		1.018	0.990–1.046	0.208
Gender	0.633	0.190–2.105	0.456		0.862	0.470–1.582	0.632
Location	0.924	0.524–1.631	0.786		1.321	1.002–1.742	0.048	0.700
Margin status	4.401	1.152–16.810	0.030	0.622
Adjuvant treatment	0.796	0.346–1.831	0.591		4.505	2.587–7.845	<0.001
Lauren classification	1.307	0.729–2.344	0.369		1.345	0.870–2.079	0.183
Tumor size	1.309	1.124–1.525	0.001	0.001	1.26	1.178–1.349	<0.001	0.202
Vascular invasion	2.179	0.476–9.986	0.316		9.935	3.923–25.161	<0.001	0.288
Neural invasion	2.588	0.690–9.708	0.159		7.181	3.711–13.896	<0.001	0.200
Grade	7.049	0.909–54.675	0.062		1.956	1.056–3.623	0.033	0.155
T status	1.687	0.965–2.950	0.067		3.594	2.511–5.144	<0.001	<0.001
N status	1.468	0.907–2.378	0.118		3.484	2.492–4.871	<0.001	<0.001
VEGFR2/CD31 (high vs low)	3.163	0.999–10.008	0.050	0.047	2.057	0.813–5.206	0.128

Bold values are statistically significant (p < 0.05)